ADIAL PHARMACEUTICALS, INC. Research And Development Expense

Quick Answer

ADIAL PHARMACEUTICALS, INC. reported Research And Development Expense of $2.62 million for the year ending 2025.

  • ADIAL PHARMACEUTICALS, INC. showed a decrease of -18.9% in Research And Development Expense from 2024 to 2025.
  • This data is from ADIAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), ADIAL PHARMACEUTICALS, INC.'s Research And Development Expense has grown by 1,338.5%.
  • Historical annual values: Fiscal year 2025: $2.62 million | Fiscal year 2024: $3.23 million | Fiscal year 2023: $1.27 million | Fiscal year 2022: $1.95 million | Fiscal year 2021: $8.40 million | Fiscal year 2020: $5.85 million | Fiscal year 2019: $3.97 million | Fiscal year 2018: $368.5 thousand | Fiscal year 2017: $182.1 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: